We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+6.42%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$1.45B
AUM Growth
+$336M
Cap. Flow
+$603M
Cap. Flow %
41.48%
Top 10 Hldgs %
67.23%
Holding
768
New
375
Increased
70
Reduced
59
Closed
238

Sector Composition

Rank Sector Weight
1 Healthcare 11.15%
2 Financials 9.75%
3 Technology 2.87%
4 Industrials 2.67%
5 Consumer Discretionary 1.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHAQ.WS
451
DELISTED
Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half (
CHAQ.WS
$21K ﹤0.01%
+21,977
New +$24.3K
BMRN icon
452
CALL
BioMarin Pharmaceuticals
BMRN
$13.5B
$20K ﹤0.01%
15,000
-14,300
-49% -$1.17M
JWSM.WS
453
DELISTED
Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
JWSM.WS
$20K ﹤0.01%
+17,400
New +$20.3K
MU icon
454
CALL
Micron Technology
MU
$981B
$19K ﹤0.01%
+12,500
New +$1.06M
OTIS icon
455
PUT
Otis Worldwide
OTIS
$27.8B
$19K ﹤0.01%
+19,900
New +$1.3M
ALNY icon
456
PUT
Alnylam Pharmaceuticals
ALNY
$29.6B
$18K ﹤0.01%
+5,000
New +$752K
GME icon
457
PUT
GameStop
GME
$8.44B
$18K ﹤0.01%
276,000
-124,000
-31% -$3.66M
SPY icon
458
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$807B
$18K ﹤0.01%
105,000
+90,000
+600% +$34.7M
CAS.WS
459
DELISTED
Cascade Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class
CAS.WS
$18K ﹤0.01%
+20,300
New +$26.6K
CNST
460
CALL
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$18K ﹤0.01%
+30,700
New +$930K
ALNY icon
461
CALL
Alnylam Pharmaceuticals
ALNY
$29.6B
$17K ﹤0.01%
+6,000
New +$903K
SAND
462
CALL
DELISTED
Sandstorm Gold
SAND
$17K ﹤0.01%
28,300
LHC.WS
463
DELISTED
Leo Holdings Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
LHC.WS
$17K ﹤0.01%
+22,500
New +$22.6K
GNRSW
464
DELISTED
Greenrose Acquisition Corp. Warrant
GNRSW
$17K ﹤0.01%
20,000
-5,000
-20% -$6.97K
BLUE
465
PUT
DELISTED
bluebird bio
BLUE
$16K ﹤0.01%
+718
New +$354K
TVTX icon
466
CALL
Travere Therapeutics
TVTX
$5.68B
$16K ﹤0.01%
+25,000
New +$691K
MAACW
467
DELISTED
Montes Archimedes Acquisition Corp. Warrant
MAACW
$16K ﹤0.01%
+18,845
New +$26.3K
GE icon
468
GE Aerospace
GE
$382B
$15K ﹤0.01%
+234
New +$14.2K
MSOS icon
469
PUT
AdvisorShares Pure US Cannabis ETF
MSOS
$930M
$15K ﹤0.01%
+75,000
New +$3.46M
NRACW
470
DELISTED
Northern Revival Acquisition Corporation Warrant
NRACW
$15K ﹤0.01%
+21,542
New +$15.1K
BURU.WS
471
DELISTED
Nuburu, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
BURU.WS
$15K ﹤0.01%
14,900
-47,357
-76% -$79.8K
SWETW
472
DELISTED
Athlon Acquisition Corp. Warrant
SWETW
$15K ﹤0.01%
+28,328
New +$21.1K
TMAC.WS
473
DELISTED
The Music Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
TMAC.WS
$15K ﹤0.01%
+25,000
New +$16.3K
AMC icon
474
PUT
AMC Entertainment Holdings
AMC
$2.14B
$14K ﹤0.01%
20,800
-33,620
-62% -$2.57M
BREZW
475
DELISTED
Breeze Holdings Acquisition Corp. Warrant
BREZW
$14K ﹤0.01%
+20,000
New +$21.1K

Similar funds

Cowen and Company's Q1 2021 Portfolio in Review

As of Q1 2021, Cowen and Company held 768 positions worth $1.45B, up 30% from $1.12B the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Cowen and Company deployed $603M of net new capital in Q1 2021, opening 375 new positions and adding to 70 existing holdings. Its largest new stake was iTeos Therapeutics: 588,238 shares worth $20.1M.

By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 4.9% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Freeport-McMoran, an estimated $5.42M trimmed.

  • Cowen and Company's largest Q1 2021 buy was iTeos Therapeutics: 588,238 shares worth $20.1M.
  • Cowen and Company added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q1 2021, an estimated $151M increase.
  • Cowen and Company's biggest Q1 2021 reduction was Freeport-McMoran, cutting an estimated $5.42M.
  • Cowen and Company fully exited VanEck Semiconductor ETF in Q1 2021, selling an estimated $30.8M.
  • Cowen and Company's ten largest holdings make up 67% of its $1.45B portfolio in Q1 2021.
  • Cowen and Company opened 375 new positions and closed 238 in Q1 2021.
  • Cowen and Company's portfolio value rose 30% quarter-over-quarter to $1.45B.

Based on Cowen and Company's 13F filing for Q1 2021, filed 4 May 2021.